Drug Delivery: Dendritic Mesoporous Silica Nanoparticles for pH‐Stimuli‐Responsive Drug Delivery of TNF‐Alpha (Adv. Healthcare Mater. 13/2017)

In article number 1700012, Helmut Jonuleit and co‐workers utilize dendritic mesoporous silica nanoparticles for drug delivery to increase the efficacy of anti‐tumor drug TNF‐α, while decreasing its side‐effects.

Saved in:
Bibliographic Details
Published in:Advanced healthcare materials 2017-07, Vol.6 (13), p.n/a
Main Authors: Kienzle, Arne, Kurch, Sven, Schlöder, Janine, Berges, Carsten, Ose, Robert, Schupp, Jonathan, Tuettenberg, Andrea, Weiss, Henning, Schultze, Jennifer, Winzen, Svenja, Schinnerer, Meike, Koynov, Kaloian, Mezger, Markus, Haass, Nikolas K., Tremel, Wolfgang, Jonuleit, Helmut
Format: Article
Language:English
Subjects:
Anticancer properties
Drug delivery
Drug delivery systems
mesoporous silica nanoparticles
Nanoparticles
pH‐triggered release
Porous materials
proinflammatory cytokine
Silica
Silicon dioxide
Stimuli
stimuli‐responsive drug delivery
Tumor necrosis factor
tumor necrosis factor‐alpha
Workers
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In article number 1700012, Helmut Jonuleit and co‐workers utilize dendritic mesoporous silica nanoparticles for drug delivery to increase the efficacy of anti‐tumor drug TNF‐α, while decreasing its side‐effects.
ISSN:2192-2640
2192-2659
DOI:10.1002/adhm.201770066